Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer

Human Gene Therapy

Volumn 16, Issue 7, 2005, Pages 845-858

  Zhao, Lili ^a   Gu, Jinfa ^a   Dong, Aiwen ^a   Zhang, Yanhong ^a   Zhong, Liu ^a   He, Lingfeng ^a   Wang, Yigang ^b   Zhang, Jinhe ^a   Zhang, Zilai ^a   Huiwang, Jin ^a   Qian, Qijun ^b,c   Qian, Cheng ^b,d   Liu, Xinyuan ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; CASPASE 9; DNA FRAGMENT; INTERLEUKIN 24; LIPOCORTIN 5; MDA 7 PROTEIN; ONCOLYTIC VIRUS; ONYX 015; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS ONCOLYSATE;

ADENOVIRUS ZD55; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN BEL7404; CELL STRAIN HCT116; CELL STRAIN HT29; CELL STRAIN SW480; CELL STRAIN SW620; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; GENE DELETION; GENE INSERTION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG FIBROBLAST; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; TUMOR XENOGRAFT; VIRAL GENE THERAPY; VIRUS RECOMBINANT; VIRUS REPLICATION; WESTERN BLOTTING;

ADENOVIRIDAE; ADENOVIRUS E1B PROTEINS; ANIMALS; APOPTOSIS; CASPASES; CELL LINE; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMANS; INTERLEUKINS; MICE; MICE, INBRED BALB C; MICE, NUDE; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE;

EID: 22144457587     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.845     Document Type: Article

References (46)

1. BISCHOFF, J.R., KIRN, D.H., WILLIAMS, A., HEISE, C., HORN, S., MUNA, M., NG, L., NYE, J.A., SAMPSON-JOHANNES, A., FATTAEY, A., and MCCORMICK, F. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373-376.
2. CAO, X.X., MOHUIDDIN, I., CHADA, S., MHASHILKAR, A.M., OZVARAN, M.K., MCCONKEY, D.J., MILLER, S.D., DANIEL, J.C., and SMYTHE, W.R. (2002). Adenoviral transfer of mda-7 leads to BAX up-regulation and apoptosis in mesothelioma cells, and is abrogated by over-expression of BCL-XL. Mol. Med. 8, 869-876.
3. CHADA, S., SUTTON, R.B., EKMEKCIOGLU, S., ELLERHORST, J., MUMM, J.B., LEITNER, W.W., YANG, H.Y., SAHIN, A.A., HUNT, K.K., FUSON, K.L., POINDEXTER, N., ROTH, J.A., RAMESH, R., GRIMM, E.A., and MHASHILKAR, A.M. (2004). MDA-7/IL-24 is a unique cytokine tumor suppressor in the IL-10 family. Int. Immunopharmacol. 4, 649-667.
4. CHAIKEN, I.M., and WILLIAMS, W.V. (1996). Identifying structure-function relationships in four-helix bundle cytokines: Towards de novo mimetic design. Trends Biotechnol. 14, 369-375.
5. DOBBELSTEIN, M. (2004). Replicating adenoviruses in cancer therapy. Curr. Top. Microbiol. Immunol. 273, 291-334.
6. EKMEKCIOGLU, S., ELLERHORST, J.A., MUMM, J.B., ZHENG, M., BROEMELING, L., PRIETO, V.G., STEWART, A.L., MHASHILKAR, A.M., CHADA, S., and GRIMM, E.A. (2003). Negative association of melanoma differentiation associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. Mol. Cancer Ther. 2, 9-17.
7. ELLERHORST, J.A., PRIETO, V.G., EKMEKCIOGLU, S., BROEMELING, L., YEKELL, S., CHADA, S., and GRIMM, E.A. (2002). Loss of MDA-7 expression with progression of melanoma. J. Clin. Oncol. 20, 1069-1074.
8. GEOERGER, B., GRILL, J., OPOLON, P., MORIZET, J., AUBERT, G., LECLUSE, Y., VAN BEUSECHEM, V.W., GERRITSEN, W.R., KIRN, D.H., and VASSAL, G. (2003). Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts. Br. J. Cancer 89, 577-584.
9. HEISE, C., SAMPSON-JOHANNES, A., WILLIAMS, A., MCCORMICK, F., VON HOFF, D.D., and KIRN, D.H. (1997). ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nat. Med. 3, 639-645.
10. HUANG, E.Y., MADIREDDI, M.T., GOPALKRISHNAN, R.V., LESZCZYNIECKA, M., SU, Z., LEBEDEVA, I.V., KANG, D., JIANG, H., LIN, J.J., ALEXANDRE, D., CHEN, Y., VOZHILLA, N., MEI, M.X., CHRISTIANSEN, K.A., SIVO, F., GOLDSTEIN, N.I., MHASHILKAR, A.B., CHADA, S., HUBERMAN, E., PESTKA, S., and FISHER, P.B. (2001). Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene 20, 7051-7063.
11. JIANG, H., LIN, J.J., SU, Z.Z., GOLDSTEIN, N.I., and FISHER, P.B. (1995). Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11, 2477-2486.
12. JIANG, H., SU, Z., LIN, J.J., GOLDSTEIN, N.I. , YOUNG, C.S.H., and FISHER, P.B. (1996). The melanoma differentiation associated gene mda-7 suppresses cancer cell growth. Proc. Natl. Acad. Sci. U.S.A. 93, 9160-9165.
13. KAWABE, S., NISHIKAWA, T., ROTH, J.A., CHADA, S., and MEYN, R.E. (2002). Adenovirus mediated mda-7 gene expression radiosensitizes non-small cell lung cancer cells via TP53-independent mechanisms. Mol. Ther. 6, 637-644.
14. KHURI, F.R., NEMUNAITIS, J., GANLY, I., ARSENEAU, J., TANNOCK, I.F., ROMEL, L., GORE, M., IRONSIDE, J., MACDOUGALL, R.H., HEISE, C., RANDLEV, B., GILLENWATER, A.M., BRUSO, P., KAYE, S.B., HONG, W.K., and KIRN, D.H. (2000). A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6, 879-885.
15. KIRN, D., HERMISTON, T., and MCCORMICK, F. (1998). ONYX-015: Clinical data are encouraging. Nat. Med. 4, 1341-1342.
16. KOTENKO, S.V. (2002). The family of IL-10-related cytokines and their receptors: Related, but to what extent? Cytokine Growth Factor Rev. 13, 223-240.
17. KOTENKO, S.V., KRAUSE, C.D., IZOTOVA, L.S., POLLACK, B.P., WU, W., and PESTKA, S. (1997). Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16, 5894-5903.
18. LEATH, C.A., III, KATARAM, M., BHAGAVATULA, P., GOPAL-KRISHNAN, R.V., DENT, P., FISHER, P.B., PEREBOEV, A., CAREY, D., LEBEDEVA, I.V., HAISMA, H.J., ALVAREZ, R.D., CURIEL, D.T., and MAHASRESHTI, P.J. (2004). Infectivity enhanced adenoviral-mediated mda-7/IL-24 gene therapy for ovarian carcinoma. Gynecol. Oncol. 94, 352-362.
19. LEBEDEVA, I.V., SU, Z.-Z., CHANG, Y., KITADA, S., REED, J.C., and FISHER, P.B. (2002). The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 21, 708-718.
20. LEBEDEVA, I.V., SARKAR, D., SU, Z.Z., KITADA, S., DENT, P., STEIN, C.A., REED, J.C., and FISHER, P.B. (2003). Bcl-2 and Bcl-XL differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24. Oncogene 27, 8758-8773.
21. MADIREDDI, M.T., SU, Z-Z., YOUNG, C.S., GOLDSTEIN, N.I., and FISHER, P.B. (2000). Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy. Adv. Exp. Med. Biol. 465, 239-261.
22. MAKOWER, D., ROZENBLIT, A., KAUFMAN, H., EDELMAN, M., LANE, M.E., ZWIEBEL, J., HAYNES, H., and WADLER, S. (2003). Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin. Cancer Res. 9, 693-702.
23. MHASHILKAR, A.M., SCHROCK, R.D., HINDI, M., LIAO, J., SIEGER, K., KOUROUMA, F., ZOU-YANG, X.H., ONISHI, E., TAKH, O., VEDVICK, T.S., FANGER, G., STEWART, L., WATSON, G.J., SNARY, D., FISHER, P.B., SAEKI, T., ROTH, J.A., RAMESH, R., and CHADA, S. (2001). Melanoma differentiation associated gene-7 (mda-7): A novel anti-tumor gene for cancer gene therapy. Mol. Med. 7, 271-282.
24. MHASHILKAR, A.M., STEWART, A.L., SIEGER, K., YANG, H.Y., KHIMANI, A.H., ITO, I., SAITO, Y., HUNT, K.K., GRIMM, E.A., ROTH, J.A., MEYN, R.E., RAMESH, R., and CHADA, S. (2003). MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol. Ther. 8, 207-219.
25. MORLEY, S., MACDONALD, G., KIRN, D., KAYE, S., BROWN, R., and SOUTAR, D. (2004). The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma. Clin. Cancer Res. 10, 4357-4362.
26. MULVIHILL, S., WARREN, R., VENOOK, A., ADLER, A., RANDLEV, B., HEISE, C., and KIRN, D. (2001). Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: A phase I trial. Gene Ther. 8, 308-315.
27. NEMUNAITIS, J., GANLY, I., KHURI, F., ARSENEAU, J., KUHN, J., MCCARTY, T., LANDERS, S., MAPLES, P., ROMEL, L., RANDLEV, B., REID, T., KAYE, S., and KIRN, D. (2000). Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: A phase II trial. Cancer Res. 15, 6359-6366.
28. NEMUNAITIS, J., KHURI, F., GANLY, I., ARSENEAU, J., POSNER, M., VOKES, E., KUHN, J., MCCARTY, T., LANDERS, S., BLACKBURN, A., ROMEL, L., RANDLEV, B., KAYE, S., and KIRN, D. (2001). Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J. Clin. Oncol. 19, 289-298.
29. NISHIKAWA, T., RAMESH, R., MUNSHI, A., CHADA, S., and MEYN, R.E. (2004). Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation. Mol. Ther. 9, 818-828.
30. PATAER, A., VORBURGER, S.A., BARBER, G.N., CHADA, S., MHASHILKAR, A.M., ZOU-YANG, H., STEWART, A.L., BALACHANDRAN, S., ROTH, J.A., HUNT, K.K., and SWISHER, S.G. (2002). Adenoviral transfer of the melanoma differentiation- associated gene 7 (mda7) induces apoptosis of lung cancer cells via upregulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. 62, 2239-2243.
31. PATAER, A., CHADA, S., HUNT, K.K., ROTH, J.A., and SWISHER, S.G. (2003). Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. J. Thorac. Cardiovasc. Surg. 125, 1328-1335.
32. PEI, Z., CHU, L., ZOU, W., ZHANG, Z., QIU, S., QI, R., GU, J., QIAN, C., and LIU, X. (2004). An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology 39, 1371-1381.
33. PORTELLA, G., SCALA, S., VITAGLIANO, D., VECCHIO, G., and FUSCO, A. (2002). ONYX-015, an ElB gene-defective adenovirus, induces cell death in human anaplastic thyroid carcinoma cell lines. J. Clin. Endocrinol. Metab. 87, 2525-2531.
34. REED, J.C. (1996). Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst. Mitt. 97, 72-100.
35. RIES, S.J., BRANDTS, C.H., CHUNG, A.S., BIEDERER, C.H., HANN, B.C., LIPNER, E.M., MCCORMICK, F., and KORN, W.M. (2000). Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015). Nat. Med. 6, 1128-1133.
36. SAEKI, T., MHASHILKAR, A., CHADA, S., BRANCH, C., ROTH, J.A., and RAMESH, R. (2000). Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Gene. Ther. 7, 2051-2057.
37. SAEKI, T., MHASHILKAR, A., SWANSON, X., ZOU-YANG, X.H., SIEGER, K., KAWABE, S., BRANCH, C.D., ZUMSTEIN, L., MEYN, R.E., ROTH, J.A., CHADA, S., and RAMESH, R. (2002). Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo. Oncogene 21, 4558-4566.
38. SARKAR, D., SU, Z.Z., LEBEDEVA, I.V., SAUANE, M., GOPALKRISHNAN, R.V., VALERIE, K., DENT, P., and FISHER, P.B. (2002a). Mda-7 (IL-24) mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK. Proc. Natl. Acad. Sci. U.S.A. 99, 10054-10059.
39. SARKAR, D., SU, Z.Z., LEBEDEVA, I.V., SAUANE, M., GOPALKRISHNAN, R.V., DENT, P., and FISHER, P.B. (2002b). Mda-7 (IL-24): Signaling and functional roles. Biotechniques 33, 30-39.
40. SAUANE, M., GOPALKRISHNAN, R.V., SARKAR, D., SU, Z.Z., LEBEDEVA, I.V., DENT, P., PESTKA, S., and FISHER, P.B. (2003). MDA-7/IL-24: Novel cancer growth suppressing and apoptosis inducing cytokine. Cytokine Growth Factor Rev. 14, 35-51.
41. SAUANE, M., LEBEDEVA, I.V., SU, Z.Z., CHOO, H.T., RANDOLPH, A., VALERIE, K., DENT, P., GOPALKRISHNAN, R.V., and FISHER, P.B. (2004). Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways. Cancer Res. 64, 2988-2993.
42. SHINOURA, N., YOSHIDA, Y., TSUNODA, R., OHASHI, M., ZHANG, W., ASAI, A., KIRINO, T., and HAMADA, H. (1999). Highly augmented cytopathic effect of a fiber-mutant E1B defective adenovirus for gene therapy of gliomas. Cancer Res. 59, 3411-3416.
43. SOVA, P., REN, X.W., NI, S., BERNT, K.M., MI, J., KIVIAT, N., and LIEBER, A. (2004). A tumor-targeted: and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. Mol. Ther. 9, 496-509.
44. SU, Z.-Z., MADIREDDI, M.T., LIN, J.J., YOUNG, C.S., KITADA, S., REED, J.C., GOLDSTEIN, N.I., and FISHER, P.B. (1998). The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice. Proc. Natl. Acad. Sci. U.S.A. 95, 14400-14405.
45. SU, Z.-Z., LEBEDEVA, I.V., GOPALKRISHNAN, R.V., GOLDSTEIN, N.I., STEIN, C.A., REED, J.C., DENT, P., and FISHER, P.B. (2001). A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells. Proc. Natl. Acad. Sci. U.S.A. 98, 10332-10337.
46. SU, Z.-Z., LEBEDEVA, I.V., SARKAR, D., GOPALKRISHNAN, R.V., SAUANE, M., SIGMON, C., YACOUB, A., VALERIE, K., DENT, P., and FISHER, P.B. (2003). Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 22, 1164-1180.